Medical College of Wisconsin
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Medical College of Wisconsin sits in the top decile of US sponsors by registered trial count (#79 of 15,742 sponsors by registered trial count).
Medical College of Wisconsin: 447 sponsored US clinical trials, 95 recruiting.
Medical College of Wisconsin sponsors 447 registered US clinical trials on ClinicalTrials.gov, 95 of them currently recruiting, and 236 completed. 28 of these trials are in Phase 3-4 (later-stage) and 129 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 10 trials.
Top-decile sponsor footprint
Medical College of Wisconsin ranks in the top decile of sponsors by registered trial count (#79 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
236 of 286 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
447 total, page 6 of 9
mHealth Family Self-Management
NCT03533049
Nivolumab and Tocilizumab for Relapsed Hematological Malignancy Post-allogeneic Transplant
NCT03588936
Peds SM-THINk: Nursing Interventions to Improve Discharge Outcomes
NCT03539978
Impact of Acetazolamide in Reducing Referred Postoperative Pain
NCT04470843
Effect of Curcumin on Gut Microbiota in IBS
NCT03568513
Antibiotics, Gastric Bypass, and the Microbiome
NCT05367479
Ischemic Preconditioning Claudication Study
NCT03511157
Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients
NCT03030248
Lintuzumab-Ac225 in Combination with Cladribine + Cytarabine + Filgastrim + Mitoxantrone (CLAG-M) for Relapsed/Refractory Acute Myeloid Leukemia
NCT03441048
Effect of Probiotic Supplementation on Endothelial Function II
NCT03267758
Nitric Oxide Administration During Pediatric Cardiopulmonary Bypass Surgery to Prevent Platelet Activation
NCT03455218
Defining Adolescent Nausea Through Brain Imaging and Neurostimulation Response
NCT03675321
Modulation of Type 1 Diabetes Susceptibility Through the Use of Probiotics
NCT03423589
The Effect of Sleep Extension in Teenage Girls at a College Preparatory High School
NCT04285307
Milwaukee Day Cares Indoor Air Quality Assessment and Educational Response Study
NCT03675009
Dexmedetomidine and Propofol for Pediatric MRI Sedation
NCT03513757
The Use of Deep Inspiration Breath Hold and Prone Irradiation to Decrease Cardiac Radiation Exposure
NCT03375892
The Singing Heart Study
NCT03805529
Distracting Through Procedural Pain and Distress
NCT04892160
Auricular Neurostimulation for Cyclic Vomiting Syndrome
NCT03434652
Gluten and Amylase Trypsin Inhibitors (ATI) Free Diet
NCT03443180
Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical Transplantation
NCT03159702
Oral Challenge in the Pediatric ED
NCT03404804
Counseling for Prematurity Using a Multimedia Education Tool
NCT03225885
Study of CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell
NCT03019055
Haploidentical Bone Marrow Transplantation in Sickle Cell Patients (BMTCTN1507)
NCT03263559
Development of Predictive Biomarkers
NCT03423862
Targeted Intervention for Patient Centered Outcome in Patients With Idiopathic Pulmonary Fibrosis
NCT03480451
Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)
NCT02918292
Efficacy and Pharmacogenomics of Cladribine Based Salvage Chemotherapy in Patients With Relapse/Refractory and Secondary Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)
NCT03150004
Social Network Intervention to Engage Community PLH to Engage in HIV Medical Care
NCT03157258
Observational Study to Evaluate Hematopoietic Progenitor Cell Mobilization in Patients With Newly Diagnosed Multiple Myeloma
NCT03200626
Comparison of Duodenal Stenting vs Transpyloric and Duodenal Stenting for Malignant Obstruction
NCT03125148
Vedolizumab Monotherapy Vs Combination Therapy With Tacrolimus in UC
NCT02954159
CPR Audiovisual Tool to Impact ICU Patients' Surrogate Anxiety Level.
NCT03630965
Stay on Track: A Study of Exercise Effects During Radiation
NCT03243786
Efficacy of Doxycycline on Metakaryote Cell Death in Patients With Resectable Pancreatic Cancer
NCT02775695
Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)
NCT02766465
Early Use of Vasopressin in Post-Fontan Management
NCT03088345
Physical Activity and Pacemaker Study
NCT03052829
CTSI-iPad for Vented Patient Communication
NCT03163823
Cerebral Oxygen Saturation and Cytochrome Oxidase REDOX State in Children With Epilepsy: A Pilot Study
NCT03054961
Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer
NCT03219476
Pharmacokinetic Study of Propylene Glycol-Free Melphalan HCl for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
NCT02669615
Auricular Percutaneous Electrical Nerve Field Stimulation for Postoperative Pain Control in Adults
NCT02892513
Ischemic Preconditioning as an Intervention to Improve Stroke Rehabilitation - Froedtert
NCT03023150
Phase II: Pembrolizumab/Carboplatin/Taxol in Epithelial Ovary Cancer
NCT02766582
A Study to Evaluate Steroid-free Treatment for Standard-Risk aGVHD (BMT CTN 1501)
NCT02806947
Caphosol Study: Prevention of Oral Mucositis in Children, Adolescents and Young Adults Receiving Chemotherapy
NCT02539342
Ischemic Conditioning as an Intervention to Improve Motor Function in Chronic Stroke
NCT03095755
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 49 |
| Phase 2 | 80 |
| Phase 3 | 13 |
| Phase 4 | 15 |
Therapeutic Areas
What is open in the Medical College of Wisconsin pipeline
95 recruiting of 447 indexed (21% open); 236 completed (53%).
Phase mix: 28 late (III/IV) vs 129 early (I/II) (early-phase heavy).
Top condition: Stroke (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Medical College of Wisconsin: open-pipeline peers nationwide
Peers matched on 447 registered trials and 21% open enrollment, not the therapeutic-area sidebar.
Medical College of Wisconsin sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 447 trials (± recruiting share)
- Alliance for Clinical Trials in Oncology · 446 trials · 7% recruiting
- University of Virginia · 449 trials · 22% recruiting
- Boston Children's Hospital · 462 trials · 24% recruiting
- Children's Hospital of Philadelphia · 431 trials · 18% recruiting
Sponsors near 21% open enrollment (± trial volume)
- Colorado State University · 21% recruiting · 94 trials
- University of Louisville · 21% recruiting · 217 trials
- Ohio State University · 21% recruiting · 552 trials
- Nova Southeastern University · 21% recruiting · 71 trials
Related
What to do with this Medical College of Wisconsin page
447 registered trials is a research-attention snapshot, not an endorsement of Medical College of Wisconsin or any single study.
- 95 of Medical College of Wisconsin's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Stroke is the condition Medical College of Wisconsin studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Medical College of Wisconsin pipeline card: 447 registered trials from official public datasets.Report a data error.